TCM Biotech International Corp. (4169) Stock Price & Analysis
4169 Stock Chart & Stats
- Day’s Range
- TWD 113.00 - TWD 121.00
- 52-Week Range
- TWD 113.00 - TWD 290.00
- Previous Close
- TWD 124.50
- Volume
- N/A
- Average Volume (3M)
- 145.82K
- Market Cap
- TWD 7.54B
- Enterprise Value
- TWD 13.28B
- Total Cash (Recent Filing)
- TWD 1.20B
- Total Debt (Recent Filing)
- TWD 24.88M
- Price to Earnings (P/E)
- ―
- Beta
- 0.19
- Next Earnings
- Mar 24, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 20, 2026
- Dividend Yield
- 0.28%
4169 FAQ
What was TCM Biotech International Corp.’s price range in the past 12 months?
What is TCM Biotech International Corp.’s market cap?
When is TCM Biotech International Corp.’s upcoming earnings report date?
How were TCM Biotech International Corp.’s earnings last quarter?
Is TCM Biotech International Corp. overvalued?
Does TCM Biotech International Corp. pay dividends?
What is TCM Biotech International Corp.’s EPS estimate?
How many shares outstanding does TCM Biotech International Corp. have?
What happened to TCM Biotech International Corp.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TCM Biotech International Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TCM Biotech International Corp.
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Ya Chun Wang
- Employees
- 73
- Website
- www.tcmbio.com
- Address
- 24Floor-8, No.97, Section 1, New Taipei, TP, 221416, TW
TCM Biotech International Corp. (4169) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |

